My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.

    Ladstein RG, Bachmann IM, Straume O, Akslen LA.

    J Invest Dermatol. 2012 Apr;132(4):1247-52. doi: 10.1038/jid.2011.464. Epub 2012 Feb 2.

    PMID:
    22297638
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    MEK'ing the most of p53 reactivation therapy in melanoma.

    Lee JT, Herlyn M.

    J Invest Dermatol. 2012 Feb;132(2):263-5. doi: 10.1038/jid.2011.362.

    PMID:
    22241441
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Chronology of metastasis in cutaneous melanoma: growth rate model.

    Tejera-Vaquerizo A, Nagore E, Meléndez JJ, López-Navarro N, Martorell-Calatayud A, Herrera-Acosta E, Traves V, Guillén C, Herrera-Ceballos E.

    J Invest Dermatol. 2012 Apr;132(4):1215-21. doi: 10.1038/jid.2011.433. Epub 2012 Jan 5.

    PMID:
    22217744
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Melanoma: new insights and new therapies.

    Nikolaou VA, Stratigos AJ, Flaherty KT, Tsao H.

    J Invest Dermatol. 2012 Mar;132(3 Pt 2):854-63. doi: 10.1038/jid.2011.421. Epub 2012 Jan 5. Review.

    PMID:
    22217739
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.

    Fujimura T, Ring S, Umansky V, Mahnke K, Enk AH.

    J Invest Dermatol. 2012 Apr;132(4):1239-46. doi: 10.1038/jid.2011.416. Epub 2011 Dec 22.

    PMID:
    22189788
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Axl of evil?

    Aplin AE.

    J Invest Dermatol. 2011 Dec;131(12):2343-5. doi: 10.1038/jid.2011.308.

    PMID:
    22071539
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.

    Helmbold P, Richter AM, Walesch S, Skorokhod A, Marsch WCh, Enk A, Dammann RH.

    J Invest Dermatol. 2012 Mar;132(3 Pt 1):687-94. doi: 10.1038/jid.2011.380. Epub 2011 Nov 24.

    PMID:
    22113481
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    (V600E)Braf::Tyr-CreERT2::K14-Kitl mice do not develop superficial spreading-like melanoma: keratinocyte Kit ligand is insufficient to "translocate" (V600E)Braf-driven melanoma to the epidermis.

    Rae J, Viros A, Hayward R, Bennett DC, Dhomen N, Longley BJ, Reis-Filho JS, Marais R.

    J Invest Dermatol. 2012 Feb;132(2):488-91. doi: 10.1038/jid.2011.341. Epub 2011 Nov 24. No abstract available.

    PMID:
    22113477
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Selective loss of wild-type p16(INK4a) expression in human nevi.

    Scurr LL, McKenzie HA, Becker TM, Irvine M, Lai K, Mann GJ, Scolyer RA, Kefford RF, Rizos H.

    J Invest Dermatol. 2011 Nov;131(11):2329-32. doi: 10.1038/jid.2011.197. Epub 2011 Jul 7. No abstract available.

    PMID:
    21734716
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Absence of mismatch repair deficiency-related microsatellite instability in non-melanoma skin cancer.

    Reuschenbach M, Sommerer C, Hartschuh W, Zeier M, Doeberitz MK, Kloor M.

    J Invest Dermatol. 2012 Feb;132(2):491-3. doi: 10.1038/jid.2011.326. Epub 2011 Oct 20. No abstract available.

    PMID:
    22011909
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Proteinase-activated receptors 1 and 2 regulate invasive behavior of human melanoma cells via activation of protein kinase D1.

    Kempkes C, Rattenholl A, Buddenkotte J, Strozyk E, Eberle J, Hausser A, Cevikbas F, Schneider SW, Steinhoff M.

    J Invest Dermatol. 2012 Feb;132(2):375-84. doi: 10.1038/jid.2011.314. Epub 2011 Oct 13.

    PMID:
    21993564
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk.

    Law MH, Montgomery GW, Brown KM, Martin NG, Mann GJ, Hayward NK, MacGregor S; Q-MEGA and AMFS Investigators.

    J Invest Dermatol. 2012 Feb;132(2):485-7. doi: 10.1038/jid.2011.322. Epub 2011 Oct 13. No abstract available.

    PMID:
    21993562
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    MART-1- and gp100-expressing and -non-expressing melanoma cells are equally proliferative in tumors and clonogenic in vitro.

    Aris M, Zubieta MR, Colombo M, Arriaga JM, Bianchini M, Alperovich M, Bravo AI, Barrio MM, Mordoh J.

    J Invest Dermatol. 2012 Feb;132(2):365-74. doi: 10.1038/jid.2011.312. Epub 2011 Oct 13.

    PMID:
    21993558
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition.

    Ji Z, Njauw CN, Taylor M, Neel V, Flaherty KT, Tsao H.

    J Invest Dermatol. 2012 Feb;132(2):356-64. doi: 10.1038/jid.2011.313. Epub 2011 Oct 13.

    PMID:
    21993556
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Melanoma cells control HA synthesis in peritumoral fibroblasts via PDGF-AA and PDGF-CC: impact on melanoma cell proliferation.

    Willenberg A, Saalbach A, Simon JC, Anderegg U.

    J Invest Dermatol. 2012 Feb;132(2):385-93. doi: 10.1038/jid.2011.325. Epub 2011 Oct 13.

    PMID:
    21993555
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis.

    Weischer M, Heerfordt IM, Bojesen SE, Eigentler T, Garbe C, Röcken M, Hölmich LR, Schmidt H, Klyver H, Bastholt L, Nordestgaard BG.

    J Invest Dermatol. 2012 Feb;132(2):299-303. doi: 10.1038/jid.2011.303. Epub 2011 Sep 29.

    PMID:
    21956126
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Review and cross-validation of gene expression signatures and melanoma prognosis.

    Schramm SJ, Campain AE, Scolyer RA, Yang YH, Mann GJ.

    J Invest Dermatol. 2012 Feb;132(2):274-83. doi: 10.1038/jid.2011.305. Epub 2011 Sep 29. Review.

    PMID:
    21956122
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Engineering melanoma progression in a humanized environment in vivo.

    Kiowski G, Biedermann T, Widmer DS, Civenni G, Burger C, Dummer R, Sommer L, Reichmann E.

    J Invest Dermatol. 2012 Jan;132(1):144-53. doi: 10.1038/jid.2011.275. Epub 2011 Sep 1.

    PMID:
    21881586
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Expression of the anti-apoptotic protein BAG3 in human melanomas.

    Franco R, Scognamiglio G, Salerno V, Sebastiani A, Cennamo G, Ascierto PA, Botti G, Turco MC, Rosati A.

    J Invest Dermatol. 2012 Jan;132(1):252-4. doi: 10.1038/jid.2011.257. Epub 2011 Aug 18. No abstract available.

    PMID:
    21850027
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Immunomodulation by imiquimod in patients with high-risk primary melanoma.

    Narayan R, Nguyen H, Bentow JJ, Moy L, Lee DK, Greger S, Haskell J, Vanchinathan V, Chang PL, Tsui S, Konishi T, Comin-Anduix B, Dauphine C, Vargas HI, Economou JS, Ribas A, Bruhn KW, Craft N.

    J Invest Dermatol. 2012 Jan;132(1):163-9. doi: 10.1038/jid.2011.247. Epub 2011 Aug 18.

    PMID:
    21850019
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk